Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -111,621 | -50,003 | -6,885 | 51,049 | 89,397 |
| Depreciation Amortization | 163 | 74 | 637 | 783 | 956 |
| Accounts receivable | -1,243 | 1,486 | -4,268 | -7,580 | 3,753 |
| Other Working Capital | -26,552 | -20,014 | 16,346 | -629 | 490 |
| Other Operating Activity | 22,086 | 7,875 | 39,755 | 32,416 | 11,809 |
| Operating Cash Flow | $-117,167 | $-60,582 | $45,585 | $76,039 | $106,405 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,329 | -353 | -670 | -438 | -306 |
| Purchase Of Investment | -45,959 | -9,853 | -322,722 | -224,494 | -200,569 |
| Sale Of Investment | 108,000 | 60,900 | 136,580 | 99,181 | 66,030 |
| Investing Cash Flow | $59,712 | $50,694 | $-186,812 | $-125,751 | $-134,845 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 85,774 | 83,862 | 96,387 | 4,046 | 1,558 |
| Other Financing Activity | 465 | 465 | 1,002 | 1,002 | 370 |
| Financing Cash Flow | $86,239 | $84,327 | $97,389 | $5,048 | $1,928 |
| Beginning Cash Position | 84,941 | 84,941 | 128,779 | 128,779 | 128,780 |
| End Cash Position | 113,725 | 159,380 | 84,941 | 84,115 | 102,268 |
| Net Cash Flow | $28,784 | $74,439 | $-43,838 | $-44,664 | $-26,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | -117,167 | -60,582 | 45,585 | 76,039 | 106,405 |
| Capital Expenditure | -2,329 | -353 | -670 | -438 | -306 |
| Free Cash Flow | -119,496 | -60,935 | 44,915 | 75,601 | 106,099 |